-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $70

Benzinga·08/14/2026 11:41:08
Listen to the news
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and raises the price target from $65 to $70.